SCHEMBL7975129

SCHEMBL7975129

Nc1ccc(-c2nc3ncn(Cc4ccccc4)c3c(=O)[nH]2)cc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.56
ALDH1A1 P00352 3/20 0.56
KMT2A Q03164 3/20 0.55
HPGD P15428 2/20 0.53
PNP P00491 2/20 0.49
TNKS O95271 1/20 0.49
PARP1 P09874 1/20 0.49
TNKS2 Q9H2K2 1/20 0.49
PARN O95453 1/20 0.44
CNOT7 Q9UIV1 1/20 0.44
BRD4 O60885 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
MEN1 O00255 2/20 0.41
ADORA2A P29274 1/20 0.41
MAPT P10636 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7985511 0.99 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7975265 0.93 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7984453 0.91 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7974505 0.89 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7988556 0.89 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7985058 0.88 HPGD (0.44) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7974445 0.88 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7984488 0.88 LMNA (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7984655 0.87 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7985232 0.87 HPGD (0.44) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed